E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/1/2005 in the Prospect News Biotech Daily.

Sanofi-Aventis maintained by Deutsche Bank at hold

Sanofi-Aventis AG was maintained by Deutsche Bank Securities analysts Heidi Sprang, Mark Purcell and Alex Evans at a hold rating with price target on the stock of €69 following second-quarter results. On the Paris exchange, Sanofi-Aventis shares Wednesday were down €0.80, or 1.16%, at €68.40 on volume of 8,116,073 shares versus the three-month running average of 3,436,120 shares. In the United States, Sanofi-Aventis shares Wednesday were down $0.35, or 0.82%, at $42.41 on volume of 3,123,700 shares versus the three-month running average of 1,086,580 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.